Straits Times Index
3,330.81 +0.80 (+0.02%) S&P 500
5,349.38 -4.65 (-0.09%) Dow
38,882.23 +74.90 (+0.19%) Nasdaq
17,157.23 -30.67 (-0.18%) Bitcoin USD
70,771.34 -285.62 (-0.40%) CMC Crypto 200
1,516.76 -8.04 (-0.53%)
EW Nov 2024 115.000 call
| Previous close | 1.0100 |
| Open | 1.0100 |
| Bid | 0.5500 |
| Ask | 0.7500 |
| Strike | 115.00 |
| Expiry date | 2024-11-15 |
| Day's range | 1.0100 - 1.0100 |
| Contract range | N/A |
| Volume | |
| Open interest | 15 |
ZacksBD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
Business WireFive-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
Simply Wall St.Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
